Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07631559 · ClinicalTrials.gov registry record · NA

Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs

A NA study, sponsored by University of California, San Francisco.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT07631559 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07631559, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This study builds upon an ongoing NIH-funded randomized controlled trial (R01DA053325) evaluating a Partner Navigation Intervention to increase hepatitis C virus (HCV) treatment initiation among young adult people who inject drugs (PWID) and their injecting partners in San Francisco. The proposed research includes secondary analyses of existing trial data, additional survey measures, qualitative interviews, and a pilot intervention adaptation. The study has two primary objectives. First, it examines how racialized discrimination (structural, interpersonal, and internalized) affects HCV treatment initiation and dyadic partner support processes within injecting partnerships. Second, it evaluates whether a brief, adapted "booster" partner navigation session delivered at HCV treatment completion can improve engagement in ongoing healthcare. Participants include adults (≥18 years) who inject drugs and have been diagnosed with HCV, along with their primary injecting partners. Study activities include longitudinal surveys, qualitative interviews with a subset of participants, and a pilot intervention session with follow-up evaluation. This research addresses critical gaps in understanding how social relationships and structural inequities influence healthcare engagement among PWID. Findings will inform culturally responsive adaptations to dyadic interventions and improve continuity of care in a population disproportionately affected by HCV and systemic barriers to healthcare.

Interventions

  • BEHAVIORAL Partner navigation intervention booster session

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-09-01
Est. Completion 2027-06-30
Phase NA

What the Registry Record Tells You About NCT07631559

The ClinicalTrials.gov registry entry for NCT07631559 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Partner navigation intervention booster session is the first listed.

NCT07631559 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07631559 about?

NCT07631559 is a clinical study titled "Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs". This study builds upon an ongoing NIH-funded randomized controlled trial (R01DA053325) evaluating a Partner Navigation Intervention to increase hepatitis C virus (HCV) treatment initiation among young adult people who inject drugs (PWID) and their injecting partners in San Francisco. The proposed re...

What is the current status of trial NCT07631559?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-09-01. Estimated completion is 2027-06-30.

What interventions are being tested in trial NCT07631559?

The interventions under investigation include: Partner navigation intervention booster session (BEHAVIORAL).

Who is sponsoring clinical trial NCT07631559?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.